restorex_logo-h-200, is developed with bioabsorbable polymers based on Nobel Prize awarded science

ETR

Endogenous Tissue Restoration (ETR) is a new therapeutic approach, enabling the patient’s own body to naturally restore a new heart valve. With ETR, the patient’s natural healing system develops tissue that pervades Xeltis’ heart valve, forming a new, natural and fully functional valve within it. As ETR occurs, Xeltis implants are gradually absorbed by the body. ETR is enabled by bioabsorbable polymers based on Nobel Prize awarded science.

ETR in Action

restorex_logo-h-200 

RestoreX is the world's first polymer-based technology designed to enable natural restoration of heart valve function, through a therapeutic approach called Endogenous Tissue Restoration (ETR). ETR is enabled by bioabsorbable polymers based on Nobel Prize awarded science.


Warning: Illegal string offset 'content' in /home/xeltis36/public_html/wp-content/themes/lite/templates/template-technology.php on line 82
4

Warning: Illegal string offset 'content' in /home/xeltis36/public_html/wp-content/themes/lite/templates/template-technology.php on line 90

Warning: Illegal string offset 'content' in /home/xeltis36/public_html/wp-content/themes/lite/templates/template-technology.php on line 96

Warning: Illegal string offset 'content' in /home/xeltis36/public_html/wp-content/themes/lite/templates/template-technology.php on line 104

Product Pipeline

Presented Data

Nobel
Prize-Awarded Science

Jean-Marie Lehn, Nobel Laureate Awarded 1987 Nobel Prize in Chemistry for pioneering supramolecular chemistry, the science at the basis of Xeltis’ technology.
“Supramolecular chemistry enables Xeltis technology by providing unique biochemical and biomechanical properties, delivering solutions to issues faced by traditional materials over the course of decades.” Professor Lehn is a Scientific Advisor to Xeltis.
RestoreX technology platform comprises investigational devices that are not available for sale.